p110α may also have a role in Ras-driven leukemia, since the loss of p110α caused a significant improvement in survival in a murine model of leukemia induced by oncogenic K-Ras mutations and prolonged the latency of the myeloproliferative neoplasm [105]. This evidence concerns the gene KRAS and leukemia.